RE:RE:RE:RE:The DataEnrique, That is a fairly accurate statement. Did not realise that the Data included 5 patients who were removed from the study, this completely makes any statistical conclusion skewed. The only way to draw meaningful conclusions would be to increase the sample size. We need more Patients in the study. One way to enroll more patients is to offer PDT as an option even before trying BCG. Considering the side effects are minimal and manageable, this could potentialy Fast Track the Clinical study. Getting FDA and Health Canada to go along with this requires lot of Input and Guidance from the Medical Advisory Board.... If you are looking purely from the point of benefits to the Patient, this is a very viable alternative.